What’s going on in Washington DC, and what does it mean for people with Parkinson’s?

Resources & Tools

Author: Parkinson's Life editorsPublished: 16 August 2017

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Washington DC

In the US, the debate surrounding Parkinson’s care and research funding has hit Washington DC. Learn more about the US legislation that could impact people with Parkinson’s in this month’s free webinar from the Michael J Fox Foundation 


The next episode of the Michael J Fox Foundation’s Third Thursday webinar series will focus on ‘What’s going on in Washington?’ and will be broadcast on 17 August at 12:00 EST.

Regular host Dave Iverson, principal moderator for Partners in Parkinson’s, will lead the discussion on US legislation that could impact access to Parkinson’s care and research funding.

Listeners are encouraged to engage with the debate in real time to discuss these issues and what they mean for the Parkinson’s community.

The Michael J Fox Foundation will also share resources that listeners will be able to use to help advocate this August, while United States Congress is in recess and lawmakers return to their home states to meet with constituents.

It’s free to join the live webinar – just register here up to 15 minutes before it starts. If you miss the live broadcast, you can catch up via the recording in the library archive here.


Read more: Drug repurposing: testing a drug approved for one disease for its efficacy in another

Young-onset Parkinson’s disease: the challenges and treatment options

Go Back

Share this story

Comments


Related articles


Senior couple exercising on fitness ball

Resources & Tools

Keeping step with Parkinson’s: balance, posture and gait

Register for this free, hour-long webinar

READ MORE
180306_PL_Susanna Lindvall lead

Interviews

Meet EPDA vice-president Susanna Lindvall as she gets involved in #UniteForParkinsons 2018

International Women's Day interview special

READ MORE
diabetes-drug-could-treat-Parkinsons

Advances

Can a diabetes drug be repurposed to treat Parkinson’s too?

Common diabetes drug may have potential to treat Parkinson’s

READ MORE